Other Species / Isoforms
  MAF1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K35-sm
RIESYSCkMAGDDKH
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, inhibited
  • transcription, inhibited
MAF1 (human) RIESYSCkMAGDDKH K35-sm
MAF1 (mouse) RIESYSCKMAGDDKH K35
MAF1 (rat) RIESYSCKMAGDDKH K35
S60-p
PHVLEALsPPQtsGL
Upstream
Downstream
2 16
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, induced
Kinase, in vitro:
  • mTOR (human)
Putative in vivo kinases:
  • mTOR (human)
Regulatory protein:
  • mTOR (human)
  • TBK1 (human)
Treatment
  • MMS
  • nocodazole
  • rapamycin
  • serum_starvation
  • temsirolimus
  • Torin1
  • WYE132
MAF1 (human) PHVLEALsPPQtsGL S60-p
MAF1 (mouse) PHVLEALsPPQTSGL S60-p
MAF1 (rat) PHVLEALSPPQTsGL S60
T64-p
EALsPPQtsGLsPsR
Upstream
Downstream
1 4
Effects on Biological Processes:
  • transcription, induced
Regulatory protein:
  • mTOR (human)
Treatment
  • MMS
  • temsirolimus
  • WYE132
MAF1 (human) EALsPPQtsGLsPsR T64-p
MAF1 (mouse) EALsPPQTSGLsPsR T64
MAF1 (rat) EALSPPQTsGLsPSR T64
S65-p
ALsPPQtsGLsPsRL
Upstream
0 3
Treatment
  • MMS
MAF1 (human) ALsPPQtsGLsPsRL S65-p
MAF1 (mouse) ALsPPQTSGLsPsRL S65
MAF1 (rat) ALSPPQTsGLsPSRL S65-p
S68-p
PPQtsGLsPsRLsks
Upstream
Downstream
2 14
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, induced
Kinase, in vitro:
  • mTOR (human)
Putative in vivo kinases:
  • mTOR (human)
Regulatory protein:
  • mTOR (human)
Treatment
  • MMS
  • rapamycin
  • serum_starvation
  • temsirolimus
  • Torin1
  • WYE132
MAF1 (human) PPQtsGLsPsRLsks S68-p
MAF1 (mouse) PPQTSGLsPsRLSKs S68-p
MAF1 (rat) PPQTsGLsPSRLSKs S68-p
S70-p
QtsGLsPsRLsksQG
Upstream
0 5
Treatment
  • MMS
MAF1 (human) QtsGLsPsRLsksQG S70-p
MAF1 (mouse) QTSGLsPsRLSKsQG S70-p
MAF1 (rat) QTsGLsPSRLSKsQG S70
S73-p
GLsPsRLsksQGGEE
0 7
MAF1 (human) GLsPsRLsksQGGEE S73-p
MAF1 (mouse) GLsPsRLSKsQGGED S73
MAF1 (rat) GLsPSRLSKsQGGED S73
K74-ub
LsPsRLsksQGGEEE
0 3
MAF1 (human) LsPsRLsksQGGEEE K74-ub
MAF1 (mouse) LsPsRLSKsQGGEDE K74
MAF1 (rat) LsPSRLSKsQGGEDE K74
S75-p
sPsRLsksQGGEEEG
Upstream
Downstream
4 82
Effects on Modified Protein
  • activity, inhibited
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • transcription, altered
  • transcription, induced
Kinase, in vitro:
  • mTOR (human)
Regulatory protein:
  • mTOR (human)
Treatment
  • antibody
  • ischemia
  • MMS
  • nocodazole
  • rapamycin
  • serum_starvation
  • temsirolimus
  • Torin1
  • UV
  • WYE132
MAF1 (human) sPsRLsksQGGEEEG S75-p
MAF1 (mouse) sPsRLSKsQGGEDES S75-p
MAF1 (rat) sPSRLSKsQGGEDES S75-p
S85-p
GEEEGPLsDkCsRKT
0 12
MAF1 (human) GEEEGPLsDkCsRKT S85-p
MAF1 (mouse) GEDESPLSDKCSRKT S85
MAF1 (rat) GEDESPLSDKCSRKT S85
K87-ub
EEGPLsDkCsRKTLF
0 1
MAF1 (human) EEGPLsDkCsRKTLF K87-ub
MAF1 (mouse) DESPLSDKCSRKTLF K87
MAF1 (rat) DESPLSDKCSRKTLF K87
S89-p
GPLsDkCsRKTLFYL
0 3
MAF1 (human) GPLsDkCsRKTLFYL S89-p
MAF1 (mouse) SPLSDKCSRKTLFYL S89
MAF1 (rat) SPLSDKCSRKTLFYL S89
R114
DYDFSTARSHEFSRE
0 1
MAF1 (human) DYDFSTARSHEFSRE R114
MAF1 (mouse) DYDFSTArSHEFSrE R114-m1
MAF1 (rat) DYDFSTARSHEFSRE R114
R120
ARSHEFSREPSLSWV
0 1
MAF1 (human) ARSHEFSREPSLSWV R120
MAF1 (mouse) ArSHEFSrEPSLrWV R120-m1
MAF1 (rat) ARSHEFSREPSLRWV R120
S125
FSREPSLSWVVNAVN
0 1
MAF1 (human) FSREPSLSWVVNAVN S125
MAF1 (mouse) FSrEPSLrWVVNAVN R125-m1
MAF1 (rat) FSREPSLRWVVNAVN R125
T212-p
SISGSTYtPsEAGNE
Upstream
0 1
Treatment
  • MMS
MAF1 (human) SISGSTYtPsEAGNE T212-p
MAF1 (mouse) SISGSTYTPSEAGNA T212
MAF1 (rat) SISGSTYTPSEAGNA T212
S214-p
SGSTYtPsEAGNELD
Upstream
0 4
Treatment
  • MMS
MAF1 (human) SGSTYtPsEAGNELD S214-p
MAF1 (mouse) SGSTYTPSEAGNALD S214
MAF1 (rat) SGSTYTPSEAGNALD S214